Evidence map›Paper›PMID 35202467›Full record

ArticleBrain : a journal of neurology2022

A new form of axonal pathology in a spinal model of neuromyelitis optica.

Marina Herwerth, Selin Kenet, Martina Schifferer, Anne Winkler, Melanie Weber, Nicolas Snaidero, Mengzhe Wang, Melanie Lohrberg, Jeffrey L Bennett, Christine Stadelmann and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Axon degeneration: new actor in an old play.Neural regeneration research · 2023
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Marina HerwerthInstitute of Neuronal Cell Biology, Technical University of Munich, Munich, Germany.
Selin KenetInstitute of Neuronal Cell Biology, Technical University of Munich, Munich, Germany.ORCID 0000-0001-5527-3442
Martina SchiffererGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Anne WinklerInstitute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
Melanie WeberInstitute of Neuronal Cell Biology, Technical University of Munich, Munich, Germany.ORCID 0000-0003-4232-4807
Nicolas SnaideroInstitute of Neuronal Cell Biology, Technical University of Munich, Munich, Germany.
Mengzhe WangInstitute of Neuronal Cell Biology, Technical University of Munich, Munich, Germany.
Melanie LohrbergInstitute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
Jeffrey L BennettDepartments of Neurology and Ophthalmology, Programs in Neuroscience and Immunology, University of Colorado School of Medicine, Aurora, USA.
Christine StadelmannInstitute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.ORCID 0000-0003-1766-5458
Bernhard HemmerDepartment of Neurology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.ORCID 0000-0001-5985-6784
Thomas MisgeldInstitute of Neuronal Cell Biology, Technical University of Munich, Munich, Germany.
Technical University of Munich · DEUniversitätsmedizin Göttingen · DEGerman Center for Neurodegenerative Diseases · DETUM Klinikum · DEUniversity of Colorado Denver · US

Funding

Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis OpticaR01EY022936 · NEI · UNIVERSITY OF COLORADO DENVER · PI BENNETT, JEFFREY L · 2013 to 2022
$3.8M
NEI NIH HHS R01 EY022936
6 · The paper itself

Abstract

Neuromyelitis optica is a chronic neuroinflammatory disease, which primarily targets astrocytes and often results in severe axon injury of unknown mechanism. Neuromyelitis optica patients harbour autoantibodies against the astrocytic water channel protein, aquaporin-4 (AQP4-IgG), which induce complement-mediated astrocyte lysis and subsequent axon damage. Using spinal in vivo imaging in a mouse model of such astrocytopathic lesions, we explored the mechanism underlying neuromyelitis optica-related axon injury. Many axons showed a swift and morphologically distinct 'pearls-on-string' transformation also readily detectable in human neuromyelitis optica lesions, which especially affected small calibre axons independently of myelination. Functional imaging revealed that calcium homeostasis was initially preserved in this 'acute axonal beading' state, ruling out disruption of the axonal membrane, which sets this form of axon injury apart from previously described forms of traumatic and inflammatory axon damage. Morphological, pharmacological and genetic analyses showed that AQP4-IgG-induced axon injury involved osmotic stress and ionic overload, but does not appear to use canonical pathways of Wallerian-like degeneration. Subcellular analysis demonstrated remodelling of the axonal cytoskeleton in beaded axons, especially local loss of microtubules. Treatment with the microtubule stabilizer epothilone, a putative therapy approach for traumatic and degenerative axonopathies, prevented axonal beading, while destabilizing microtubules sensitized axons for beading. Our results reveal a distinct form of immune-mediated axon pathology in neuromyelitis optica that mechanistically differs from known cascades of post-traumatic and inflammatory axon loss, and suggest a new strategy for neuroprotection in neuromyelitis optica and related diseases.

Indexed as

Neuromyelitis OpticaAnimalsAquaporin 4AstrocytesAutoantibodiesAxonsHumansImmunoglobulin GMiceAquaporin 4AutoantibodiesImmunoglobulin Gaquaporin-4astrocytopathyneurodegenerationneuroinflammationneuromyelitis optica

Identifiers

PMID35202467
PMCPMC9166560
OpenAlexW4213455746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.